Trial Profile
A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2014
Price :
$35
*
At a glance
- Drugs AS 101 (Primary) ; Zidovudine
- Indications Acquired immunodeficiency syndrome
- Focus Pharmacokinetics
- Sponsors Pfizer
- 07 Apr 2014 New trial record